一、可转换公司债券基本情况 （一）可转换公司债券发行情况 经中国证券监督管理委员会（以下简称"中国证监会"）出具的《关于同意 深圳市豪鹏科技股份有限公司向不特定对象发行可转换公司债券注册的批复》 （证监许可〔2023〕1997 号）同意注册，公司于 2023 年 12 月 22 日向不特定对 象发行了 1,100.00 万张可转换公司债券，债券期限为 6 年，每张面值为人民币 100 元，募集资金总额为人民币 110,000.00 万元。 （二）可转换公司债券上市情况 | | | 债券代码：127101 债券简称：豪鹏转债 深圳市豪鹏科技股份有限公司 关于"豪鹏转债"赎回结果的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 经深圳证券交易所同意，上述可转换公司债券于 2024 年 1 月 11 日起在深圳 证券交易所挂牌交易，债券简称"豪鹏转债"，债券代码"127101"。 （三）可转换公司债券转股期限 根据相关法律法规规定及《募集说明书》的约定，"豪鹏转债"转股期间为 2024 年 6 月 28 日至 2029 年 12 月 21 日（如遇法定节假日或 ...

| 证券代码:001283 | | --- | 证券代码：001283 证券简称：豪鹏科技 公告编号：2025-095 债券代码：127101 债券简称：豪鹏转债 深圳市豪鹏科技股份有限公司 关于"豪鹏转债"摘牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 一、可转换公司债券基本情况 （一）可转换公司债券发行情况 经中国证券监督管理委员会（以下简称"中国证监会"）出具的《关于同意 深圳市豪鹏科技股份有限公司向不特定对象发行可转换公司债券注册的批复》 （证监许可〔2023〕1997 号）同意注册，公司于 2023 年 12 月 22 日向不特定对 象发行了 1,100.00 万张可转换公司债券，债券期限为 6 年，每张面值为人民币 100 元，募集资金总额为人民币 110,000.00 万元。 （二）可转换公司债券上市情况 经深圳证券交易所同意，上述可转换公司债券于 2024 年 1 月 11 日起在深圳 证券交易所挂牌交易，债券简称"豪鹏转债"，债券代码"127101"。 （三）可转换公司债券转股期限 根据相关法律法规规定及《募集说明书》 ...

今日具体限售解禁股情况如下： 智通财经APP获悉，9月5日共有2家上市公司的限售股解禁，解禁总市值约20.7亿元。 | 股票简称 | 股票代码 | 限售股类型 | 解禁股数 | | --- | --- | --- | --- | | 莱茵生物 | 002166 | 增发A股原股东配售上市 | 1.65亿 | | 豪鹏科技 | 001283 | 发行前股份限售流通 | 2274.89万 | ...

Summary of Key Points Core Viewpoint - On September 5, a total of 5 companies had their restricted shares unlocked, with a total unlock volume of 173 million shares, amounting to a market value of 1.523 billion yuan based on the latest closing price [1]. Group 1: Unlock Volume - The companies with the highest unlock volumes were Rhine Biotech (002166) with 165 million shares, Haopeng Technology (001283) with 2.5589 million shares, and Qianjiang Biochemical (600796) with 2 million shares [1]. Group 2: Unlock Market Value - The companies with the highest unlock market values were Rhine Biotech with 1.292 billion yuan, Haopeng Technology with 186 million yuan, and Wanze Shares (000534) with 26.7066 million yuan [1]. Group 3: Unlock Ratio - In terms of the proportion of unlocked shares to total share capital, Rhine Biotech had the highest ratio at 22.31%, followed by Haopeng Technology at 2.6%, and Lanfeng Biochemical (002513) at 0.36% [1].

Core Viewpoint - Haopeng Technology (001283) has successfully entered the supply chains of various types of robots, leveraging its expertise in battery cell technology and PACK module advantages to assist clients in accelerating product design and market launch [1] Group 1: Business Development - The company has established partnerships with clients in service robots, companion robots, quadruped robotic dogs, and humanoid robots [1] - The company's battery solutions are critical for enhancing the endurance, operational duration, and reliability of robotic products [1] Group 2: Product Strategy - The company aims to diversify its product offerings to better serve brand clients and meet their evolving performance requirements as robotic applications become more varied [1] - The focus on high energy density, safety, and lightweight batteries is essential for the future of robotics [1]

Core Viewpoint - The company, Haopeng Technology, has successfully entered the supply chains of various types of robots, leveraging its expertise in battery solutions to support clients in the robotics sector [2]. Group 1: Company Developments - Haopeng Technology has established itself as a battery solution provider for service robots, companion robots, quadruped robotic dogs, and humanoid robots [2]. - The company emphasizes the importance of high energy density, safety, and lightweight batteries for the performance and reliability of robotic products [2]. - The company plans to enhance its product offerings to better serve brand clients and meet their evolving performance needs as the diversity of robotic applications increases [2]. Group 2: Industry Context - The robotics industry is experiencing a diversification of applications, which necessitates advanced battery solutions to improve the operational capabilities of robots [2].

Core Viewpoint - The announcement details the share structure and the lifting of restrictions on certain shares of Shenzhen Haopeng Technology Co., Ltd, following its initial public offering (IPO) and subsequent changes in share capital due to convertible bonds and other factors [1][2]. Group 1: Share Capital Structure - The total share capital of the company before the IPO was 60,000,000 shares, which increased to 80,000,000 shares post-IPO, with 75% being restricted shares and 25% being unrestricted shares [2]. - As of August 20, 2025, the total number of shares increased to 96,324,057 due to the conversion of convertible bonds, which added 15,714,046 shares [2]. Group 2: Restricted Shares and Commitments - As of the announcement date, there were 22,759,290 restricted shares, which included pre-IPO restricted shares and shares held by executives [3]. - The shareholders applying for the lifting of restrictions, namely Zhuhai Anhao Technology Partnership and Wang Junyi, have committed to not proposing the repurchase of their shares and adhering to lock-up agreements [3][4]. Group 3: Lifting of Restrictions - The total number of shares to be released from restrictions is 2,558,940, which will change the structure of restricted and unrestricted shares [6]. - After the lifting of restrictions, the proportion of restricted shares will decrease to 20.97%, while unrestricted shares will increase to 79.03% [6]. Group 4: Compliance and Verification - The sponsor institution has verified that the lifting of restrictions complies with relevant laws and regulations, confirming that the shareholders have adhered to their commitments [7][8].

深圳市豪鹏科技股份有限公司 首次公开发行前已发行部分股份上市流通提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： | 证券代码：001283 | 证券简称：豪鹏科技 | 公告编号：2025-093 | | --- | --- | --- | | 债券代码：127101 | 债券简称：豪鹏转债 | | 1、本次解除限售的股东所持股份为首次公开发行前已发行的部分股份，限 售起始日为 2022 年 9 月 5 日，发行时承诺自股票上市之日起锁定 3 年； 2、本次解除首发限售的股东共 2 名，解除限售的股份数量为 2,558,940 股， 占公司截至 2025 年 8 月 20 日总股本（96,324,057 股）的 2.66%； 3、本次解除限售股份的上市流通日期为 2025 年 9 月 5 日（星期五）。 4、因公司向不特定对象发行可转换公司债券（以下简称"可转债"）正处 于赎回实施期，公司股份总数可能因可转债转股而发生变动。本提示性公告所载 公司股份总数及变动情况系基于截至 2025 年 8 月 20 日的股份情况进行初步测算， 未考虑 ...

世纪证券有限责任公司 1 | | 变动时间 | | 股份总数变动原因 | 变动数量 | 变动后总股 | | --- | --- | --- | --- | --- | --- | | | | | | （股） | 份数（股） | | 2024 | 年 月 6 | 日— 28 | 可转债转股导致股份总数增加 | +15,714,046 | 96,324,057 | | 2025 | 年 月 8 | 日 20 | | | | 注：截至 2025 年 8 月 20 日，公司可转债转股数量共计 18,264,045 股。公司遵照相关规定， 优先使用通过深圳证券交易所以集中竞价交易的方式回购的股份（2,549,999 股）满足可转 债转股需求，其余部分使用新增股份，由此导致公司股份总数增加 15,714,046 股。 关于深圳市豪鹏科技股份有限公司 首次公开发行前已发行部分股份上市流通的核查意见 世纪证券有限责任公司（以下简称"保荐机构"）作为深圳市豪鹏科技股份有 限公司（以下简称"豪鹏科技"或"公司"或"发行人"）的持续督导机构，根据《公 司法》《证券法》《深圳证券交易所股票上市规则》等有关规定，对豪鹏科技首 次公开发 ...

Core Viewpoint - The 11th Golden Unicorn Award for Outstanding Secretaries of the Board has been announced, with Chen Ping from Haopeng Technology receiving the New Talent Award, highlighting the importance of board secretaries in corporate governance and investor relations [1][2]. Group 1: Award Significance - The Golden Unicorn Award has recognized over 900 outstanding board secretaries in its eleven-year history, becoming a highly regarded and influential award in the industry [1]. - The evaluation criteria for the award include information disclosure quality, effectiveness of investor communication, and contributions to corporate governance and ESG initiatives [1]. Group 2: Role of Board Secretaries - Board secretaries serve as a critical link between listed companies and the capital market, acting as gatekeepers for corporate operations and advisors for capital strategies [1]. - They are responsible for transparent and efficient communication, building trust between the company, investors, regulatory bodies, and the media, which is essential for the company's long-term stability [2]. Group 3: Recognition of Chen Ping - Chen Ping's recognition as a top board secretary reflects her exceptional capabilities in capital communication, compliance governance, and strategic collaboration [2]. - The award signifies market and investor acknowledgment of Haopeng Technology's governance standards and value growth [2].